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Summary: The Enterotest® string test is an easy and non-invasive method for sampling duodenal fluid, which has
been successfully used for the analysis of duodenal microflora, as well as biliary bile acid and lipid composition.
The method was evaluated for determination of porphyrins in duodenal bile in normal subjects and subjects with
porphyria, following cholecystokinin induced gall bladder contraction; it is known that analysis of biliary porphyrins
is more discriminatory for the diagnosis of asymptomatic porphyria than their analysis in faeces or urine. Moreover,
serial analysis of bile from patients with erythropoietic protoporphyria may help in establishing their ability to
secrete protoporphyrin in bile and to assess effects of treatment.
The binding of various porphyrins to Enterotest® strings was investigated by incubating pieces of the string in
different human bile samples with low to very high porphyrin concentrations, followed by HPLC analysis of
porphyrins both in the native bile and in extracts obtained from the strings. No differences between porphyrin
composition in native bile and extracts were observed. Duodenal fluid obtained by means of the Enterotest® from
volunteers not receiving cholecystokinin showed large variations in porphyrin patterns not resembling those of
native bile. Mesoporphyrin, a secondary porphyrin derived from protoporphyrin by bacteria, was often detectable.
These data indicate that the duodenal content without cholecystokinin injection does not reflect biliary porphyrin
composition. The presence of mesoporphyrin in the whole intestinal tract, but not in seruui and bile, suggests that
there is no enterohepatic circulation of secondary porphyrins.
There was close agreement between the porphyrin ratios found with the standard duodenal intubation technique
and the Enterotest®, performed simultaneously in one healthy volunteer after induction of gall bladder contraction
by cholecystokinin. From these experiments, it was concluded that fluid adsorbed to the Enterotest® string after
gall-bladder contraction can be used to determine biliary porphyrin composition.
Since duodenal bile is diluted gall bladder bile, variable porphyrin concentrations were found when applying the
Enterotest® in combination with cholecystokinin in the same subject on successive days. However, porphyrin ratios,
such as the protoporphyrin to coproporphyrin I ratio, were relatively constant.
In subjects with symptomatic variegate porphyria, the Enterotest® showed highly aberrant porphyrin patterns, with
increased protoporphyrin to coproporphyrin I ratios and, in addition, the presence of some unknown porphyrins. A
deviating biliary protoporphyrin/coproporphyrin I ratio in one patient appeared to be a useful diagnostic index for
the presence of latent variegate porphyria (or variegate porphyria in remission).
Finally, the Enterotest® method is also useful for monitoring patients with erythropoietic protoporphyria for their
ability to secrete protoporphyrin via bile, evaluated by measurement of protopo hyrin/coproporphyrin I and III
ratios in Enterotest® strings.
We conclude that the Enterotest® is a valuable tool for investigating porphyrin metabolism and biliary secretion
in humans.
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Introduction
Porphyrias comprise a group of autosomal inherited dis-
orders of haem synthesis (1). Variegate porphyria is clin-
ically characterized by attacks leading to photosensitiv-
ity and neurologic dysfunction. This variant is usually
symptomless in periods between attacks, which can be
evoked by drugs, alcohol, hormones, stress, infection or
starvation (2). During attacks, porphyrin levels in urine
and faeces are very high, and enable diagnosis of the
disease (3). Identification of porphyric carriers is impor-
tant because potentially fatal attacks can be prevented
by avoiding porphyrogenic drugs and circumstances (4).
However, in the latent phase only increased porphyrins
in bile are detectable, because food, bacteria and haem-
orrhage in the gut blur the borderline between normal
and abnormal porphyrin patterns in faeces, but not in
bile (5).
Erythropoietic protoporphyria is a disease with severe
photosensitivity and multiple cutaneous eruptions after
sun exposure.· lit can develop into liver cirrhosis and ful-
minant liver failure, due to hepatic protoporphyrin accu-
mulation (6—10). Biliary protoporphyrin excretion can
be useful for evaluating the capacity of the liver to
excrete this substance in this condition (11).
Thus, examination of porphyrins in bile has potential
clinical value in certain situations. Although gall bladder
bile is an excellent medium for this purpose, its collec-
tion is elaborate and extremely unpleasant for patients.
This is probably the main reason that the porphyrin com-
position of bile is rarely investigated for diagnostic
purposes (11 — 13). At present, the duodenal intubation
technique is the only non-surgical method for obtaining
duodenal bile (5). Duodenal bile can be considered as
diluted gall bladder bile, consisting of a mixture of duo-
denal, gastric and pancreatic secretions. In addition, bili-
ary porphyrin concentrations strongly depend on the re-
tention time of bile in the gall bladder. In principle, in-
terpretation of results obtained with duodenal fluid is
not necessarily hampered by these facts, as dilution and
concentration effects can be eliminated by using ratios
instead of absolute concentrations. For instance, the pro-
toporphyrin/bile acid ratio has been used for diagnostic
purposes (5, 11). In this study, we demonstrate that por-
phyrin ratios can fulfil a similar role in the bile of sub-
jects with porphyria.
Although advances in the intubation technique for ob-
taining duodenal bile have been made, such as speed of
performance and control of the zone from which the
sample is obtained (5), patient discomfort, radiation bur-
den, and equipment requirements for tube placement and
control of position remain the principal drawbacks of
this technique. We therefore looked for a more conve-
nient sampling method to obtain duodenal bile. The En-
terotest® is an accurate, simple and non-invasive diag-
nostic tool, so far successfully used for sampling duode-
nal fluid for detection of microorganisms and analysis
of bile acids and lipid composition (15—18). We antici^
pated that the Enterotest® would also permit an easier
and more routine measurement of pprphyrins in duode-
nal bile, than is at present possible with the standard
duodenal sondage techniques. Therefore a study was
performed to investigate the usefulness of the En^
terotest® as a new diagnostic tool for evaluation of por-
phyrin secretion in subjects with porphyria, using both
duodenal fluid (duodenal contents sampled without gall
bladder contraction) or duodenal bile (duodenal content
sampled 15 minutes after contraction of the gall blad-
der).
Subjects, Materials and Methods
Subjects
The participants in this study were 7 healthy volunteers (20-60
years, 3 females and 4 males), 5 females (49-66 years) and 3
males (47-53 years) with proven variegate porphyria, one female
(50 years) suspected of latent variegate porphyria, and two females
(34-39 years) with erythropoietic protoporphyria, who had un-
dergone orthotopic liver transplantation. More details of the latter
two subjects are given elsewhere (13, 19). A number of participants
underwent the Enterotest® more than once.
Materials
Porphyrin standards were obtained from Porphyrin Products, Lo-
gan, USA.
Cholecystokinin octapeptide was purchased from Ferring Pharma-
ceuticals, Malm0, Sweden. The Enterotest® was from Health De-
velopment Corp., Mountain View, CA, USA.
Enterotest®
The Enterotest® consists of a gelatine-encapsulated nylon string,
which has to be swallowed with water while one end is taped at
the corner of the mouth. The gelatine capsule dissolves in the stom-
ach, and the string, which is heavier at its distal end, enters the
duodenum by peristalsis in the following few hours or less. The
upper intestinal fluid is adsorbed on the string, which is then reco-
vered by withdrawing from the mouth. Patients and volunteers
were in a fasting state, otherwise no special instructions were given
concerning their behaviour during the test (18).
After pulling out, the pH of the string was checked with the pH
stick supplied with the Enterotest®. The string part with a pH > 7
was cut into lengths of 10 cm, which were placed in preweighed
Eppendorf cups, then weighed. Weight differences without correc-
tions for the weight of the string itself were used for the calculation
of the amount of fluid adsorbed on the string. This enables the
investigation of the porphyrin content of different parts of the
string. The pieces were eluted with an acid solution and a solution
containing the internal standard (500 nmol/1 deuteroporphyrin in a
0.8 mol/1 sulphosalicylic acid solution), or they were extracted with
a freshly prepared solution of diethyl ether/acetic acid, also after
addition of the internal standard solution (20).
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Incubation of duodenal sondage samples or native bi le
with pieces of Enterotest® string
A, B and C bile samples used in this study were obtained by duode-
nal sondage techniques as described previously (21), whereas bile
of erythropoietic protoporphyria patients, who had undergone or-
thotopic liver transplantation, was collected by means of a tempo-
rary implanted T-tube as described previously (22).
Two 10 cm pieces of the Enterotest were incubated in 2.0 ml ali-
quots of these bile samples for 1 hour. In this way, several bile
samples with different porphyrin concentrations were incubated.
These strings were investigated for their porphyrin content, using
both HC1 elution and ether extraction, and the results were com-
pared with those obtained from direct investigation of porphyrins
in the corrresponding native bile samples.
Unst imula ted duodenal f luid
Four hours after being swallowed by a subject in a fasting state,
the Enterotest® string was retrieved and stored at -20 °C until
analysis of porphyrins.
St imulated duodenal bile
The Enterotest® string was swallowed by preference at night at
home. The next morning at hospital, or in some cases at home, gall
bladder contraction was induced by intramuscular administration
of cholecystokinin at a dose of 20 ng/kg of body weight given as
bolus injection in the upperleg, or given intravenously as a dilution
with 9 g/1 saline, according to the instructions of the manufacturer.
Exactly 15 minutes after injection, the Enterotest® string was re-
trieved for porphyrin analysis, which was performed on 10 cm
pieces of the yellow and white parts of the string.
Comparison of duodenal sondage samples and
Enterotest® strings
Results from the standard duodenal intubation technique for sam-
pling bile were compared with those of the Enterotest®. For this
purpose, a string was applied to the pharynx, and the location of
the tube was determined by X-ray. By means of vacuum drainage
a portion of 1 ml of unstimulated duodenal fluid was sampled, fol-
lowed by induction of gall bladder contraction with cholecysto-
kinin (intramuscularly). Immediately after sampling a portion of
2 ml of dark yellow „B" bile, both the string and tube were re-
trieved. The distal dark yellow coloured end and the proximal un-
coloured part of the string were investigated for porphyrins with
the HC1 elution method.
Determination of porphyrins in urine, faeces, bi le and
duodenal sondage samples
Porphyrins in urine, faeces and bile were analysed according to
previously described methods (13,20, 23). Duodenal sondage sam-
ples were treated as bile samples.
Determination of porphyrins adsorbed on the string
using the HC1 elution method
In Eppendorf cups, 10 cm lengths of Enterotest® string were eluted
with 100 μΐ of 3mol/l and 50 μΐ of the internal standard solution,
thoroughly mixed with a vortex mixer and centrifuged at 13000g
for 5 min at room temperature. Aliquots of 50 μΐ of the clear super-
natant were injected onto the HPLC column.
Determination of porphyrins adsorbed on the string
using the ether extraction method
In glass stoppered tubes, 50 μΐ of the internal standard solution
were added to 10 cm lengths of string, and the porphyrins were
extracted twice with 2.0 ml of a freshly prepared ether-glacial ace-
tic acid solution (3 : 1, by vol.). The ether layers were combined
and evaporated under a stream of nitrogen in a heater set at 30 °C.
The porphyrins were dissolved in a 300 μΐ solution of 3 mol/1 HC1,
and 50 μΐ of the dissolved residue were injected onto the HPLC
column.
Statist ical calculat ions
Group means were compared by the Student t-test. Differences
were considered significant if ρ values were less than or equal
to 0,05.
Results and Discussion
Validation of the Enterotest®
We started our investigation on the usefulness of the
Enterotest® procedure with "in vitro" experiments. Re-
sults of porphyrin analysis on pieces of string incubated
in 2.0 ml portions of bile, with low to high concentra-
tions of coproporphyrin I, coproporphyrin III and proto-
porphyrin, were compared with those obtained from di-
rect porphyrin analyses in the same (native) bile sam-
ples. Moreover, we compared porphyrin profiles in na-
tive bile samples before and after incubation with
Enterotest® string. In this way, we aimed to establish
whether porphyrin profiles, determined after adsorption
of biliary porphyrins on string, differ from those of na-
tive samples, e.g. due to preferential binding of porphy-
rins to the string or to incomplete desorption of the ad-
sorbed porphyrins from the string. For the analysis of
porphyrins adsorbed on pieces of string, both the "HC1
elution method" and the "ether extraction method"
were employed.
In figure 1, four porphyrin profiles from the same bile
sample (of a non-porphyric subject) are shown: one in
native bile, one in native bile after incubation with
string, one in incubated string analysed by the HC1 elu-
tion method and one in incubated string analysed by the
ether extraction method. This figure clearly demon-
strates a good qualitative correspondence between the
profiles. The same applies when quantitative results, ob-
tained for the three main biliary porphyrins, copropor-
phyrin I, coproporphyrin III and protoporphyrin, were
compared by linear regression analysis, using ten dif-
ferent bile samples. All possible pairs of analytical
methods were considered. The derived slopes, intercepts
and squared correlation coefficients (R2) are given in
table 1. Paired t-tests showed no statistical differences
between the corresponding samples. The correlation co-
efficients for the porphyrins found in native bile and
determined with the two string methods (HC1 elution
and ether extraction), are good, the HC1 elution method
showing a somewhat better score. The latter method
gives slopes of approximately 1 for the coproporphyrins,
Eur J din Chem din Biochem 1995; 33 (No 7)
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Fig. l Chromatograms of porphyrins in bile obtained by different
methods, showing absence of preferential binding of porphyrins to
the Enterotest® string.
a) native bile sample;
b) bile recovered from 10 cm string and processed according to
the "HC1 elution" method;
c) bile after incubation with two pieces of 10 cm string;
d) bile recovered by 10 cm string and processed according to the
"ether extraction" method.
Peak numbers: 1: coproporphyrin I; 2: coproporphyrin III; 3: in-
ternal standard deuteroporphyrin; 4: protoporphyrin; 5 and 6 are
unknown compounds.
with intercepts smaller than those of the extraction
method. However, the recovery (slope) of protoporphy-
rin is somewhat higher for the ether extraction method
than for the HC1 elution method. Apparently, there is
some loss of protoporphyrin in the HC1 elution method,
but the found concentrations are still fairly comparable
to those found in native bile. The correlation coefficients
found by comparison of the results obtained for two
string methods with those obtained for native or incu-
bated bile suggest that Enterotest® results for all porphy-
rins correspond well with those found in native bile. Al-
together, from figure 1 and the results shown in table 1,
we conclude that the Enterotest® string does not prefer-
entially bind specific porphyrin species. The ether ex-
traction method is more laborious than the HC1 elution
method, and, in addition, the extracts contain more non-
porphyric compounds (see fig. Id). Furthermore, if uro-
porphyrin is present in bile (normally very low to ab-
sent), this will not be recovered by the ether extraction
method. Therefore the HC1 method was used in subse-
quent studies.
The Enterotest® applied to normal volunteers
without and with gall bladder contraction
We investigated porphyrin profiles from Enterotest®
strings swallowed by seven healthy volunteers to see
whether the porphyrin profiles corresponded with those
reported for normal human bile (either gall bladder bile
or duodenal aspirates). Human bile is characterized by
relatively high concentrations of coproporphyrin I,
lower concentrations of coproporphyrin III and a rela-
tively low concentration of protoporphyrin (6^20 times
lower than coproporphyrin I) (12, 13). Secondary por-
phyrins, like deutero-, meso-, and pemptoporphyrin are
absent from normal human bile (13). Our reference väl-
Tab. 1 Linear regression values for methods of porphyrin analy-
ses in bile for in-vitro validation of non-preferential binding of
porphyrins by Enterotest® strings. The concentrations for different
biliary porphyrins ranged from 0-4000 nmol/1 (coproporphyrin I),
from 0-3800 nmpl/1 (coproporphyrin III) and from 0-7200 nmol/1
(protoporphyrin).
R2: squared coefficient of correlation.
"Native": native bile samples; "incubated": bile samples after incu-
bation with pieces of string; "elution": incubated pieces of string
processed by the "HC1 elution" method; "extraction": incubated
pieces of string processed by the "ether extraction" method.
Independent: x-axis; Dependent: y-axis.
Porphyrin species
Coproporphyrin I
Coproporphyrin III
Protoporphyrin
Independent
Native
Native
Native
Incubated
Incubated
Elution
Native
Native
Native
Incubated
Incubated
Elution
Native
Native
Native
Incubated
Incubated
Elution
Dependent
Incubated
Elution
Extraction
Elution
Extraction
Extraction
Incubated
Elution
Extraction
Elution
Extraction
Extraction
Incubated
Elution
Extraction
Elution
Extraction
Extraction
Intercept
11.5
-10.5
39.8
0.6
46.7
53.7
14.0
-11.9
17.3
-3.4
29.1
32.0
-3.8
-0.1
11.5
-6.0
3.1
8.9
Slope
0.960
0.984
0.884
1.040
0.842
0.788
0.871
1.141
0.795
1.042
0.676
0.644
1.089
0.658 ,
0.707
0.870
1.009
1.170
R2
0.9890
0.9845
0.9452
0.9669
0.9347
0.9142
0.9973
0.9905
0.8565
0.9143
0.7506
0.8073
0.9984
0.9974
0.9532
0.9737
0.9482
0.9901
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ues are: coproporphyrin I: < 400 nmol/1, coproporphy-
rin III: < 400 nmol/1 and protoporphyrin: < 40 nmol/1
bile.
After withdrawing strings from the upper intestine of
healthy volunteers without injection of cholecystokinin,
it was noted that the strings were not homogeneously
coloured and contained white, brown, and yellow areas.
Therefore, we divided the strings into 10 cm pieces re-
gardless of the colour. Porphyrin profiles in the first and
fifth piece of string are depicted in figure 2a and 2b and
the derived concentrations of the observed porphyrins in
all eight pieces of string in figure 2c and 2d, demonstrat-
ing a non-homogeneous distribution of porphyrins along
the length of the string. Furthermore, these porphyrin
profiles do not resemble at all the characteristic patterns
obtained from normal human bile as shown in figure
1. Protoporphyrin is the predominant porphyrin in this
duodenal fluid and mesoporphyrin is frequently detect-
able. Mesoporphyrin is a dicarboxylic porphyrin derived
from protoporphyrin by bacterial conversion (23).
Levels of uroporphyrin in unstimulated duodenal fluid
ranged from undetectable to levels of 36 nmol/1. The
coproporphyrin levels (coproporphyrin I often being ab-
sent) were always lower than the protoporphyrin levels,
and low to high protoporphyrin concentrations were de-
tected from day to day when the Enterotest® was per-
formed on consecutive days in the same volunteers. Por-
phyrins in these samples presumably originate largely
from food products and/or are produced by bacteria in
the gut (23, 24). This experiment indicates that duodenal
fluid without induction of gall bladder contraction can-
not be used for the analysis of biliary porphyrin compo-
sition. On the other hand, the results permit conclusions
as to the presumed presence of an enterohepatic circula-
tion of porphyrins, as proposed by Pimstone et al. (25).
In a previous study from our laboratory, no traces of
dicarboxylic porphyrins like meso-, pempto-, and deut-
eroporphyrin could be demonstrated in serum and bile,
whereas these porphyrins are found in huge amounts in
faeces (13, 23). From these results were concluded that
there is no enterohepatic circulation of dicarboxylic por-
phyrins at the distal part of the intestinal tract (13). In
the present study we found mesoporphyrin in the duode-
num and upper bowel. We now conclude that there is
no, or at most a negligible, enterohepatic circulation of
dicarboxylic porphyrins in the whole intestinal tract. A
third conclusion is that porphyrins are not homoge-
neously distributed in duodenum and upper bowel.
Although the Enterotest® used in this way did not yield
porphyrin patterns representative of human bile, we rea-
soned that these could possibly be obtained after injec-
tion of cholecystokinin to enforce gall bladder con-
JL
10
40
20
20 30 10
Retention time [min]
300
'8200
1
20 30
20 40 60 80 0 20 40
Longitudinal axis [cm]
60 80
Fig. 2 Porphyrin profiles and concentrations in the longitudinal
axis of an Enterotest® string from duodenal and upper bowel fluid
of a healthy volunteer, performed under unstimulated conditions.
The whole nylon string had a pH > 7. Therefore the string (80 cm)
was out into lengthsiof 10 cm. For explanation of the peak numbers
see figure 1 and additionally peak number 7 (mesoporphyrin) and
8 (uroporphyrin).
a) porphyrin chromatogram from the first 10 cm of the string;
b) porphyrin chromatogram from the fifth piece;
c) coproporphyrin I, coproporphyrin III and uroporphyrin concen-
trations;
d) protoporphyrin concentrations, in each of the obtained eight
pieces of string.
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traction. Therefore, a healthy volunteer swallowed an
Enterotest® string at night, and received an intramuscu-
lar injection of cholecystokinin at the hospital the next
morning. Fifteen minutes later the string was recovered.
The proximal part of the string was uncoloured whereas
the distal part was dark yellow. Porphyrin profiles of
both parts are shown in figure 3a and 3b respectively.
The porphyrin pattern in figure 3a (high protoporphyrin,
but low coproporphyrins) does not look like the normal
biliary pattern as shown in figure 1, in contrast to the
closely similar pattern depicted in figure 3b (high copro-
porphyrins, low protoporphyrin). Apparently the colour
of the strings is indicative of the presence of adsorbed
duodenal bile. Yellow-coloured pieces of string after
cholecystokinin injection yield porphyrin patterns char-
acteristic for bile.
Definite proof that the Enterotest® after cholecystokinin
injection is an excellent substitute for intubation was
provided by the following "in vivo" experiment. This
experiment included combined sampling of duodenal
sondage fluid and the technique of the Enterotest® string
in the same healthy volunteer as in figure 3a and 3b.
Duodenal fluid was aspirated as usual before chole-
cystokinin injection and immediately thereafter. Again,
after gall bladder contraction and withdrawal of tube and
string, the proximal part of the string was white and the
distal part of the string yellow-coloured. Both the yellow
and white parts of the string as well as the the two duo-
denal sondage samples were investigated for porphyrin
composition; the resulting porphyrin profiles are shown
in figure 3c-3f. Figure 3c, the porphyrin profile of duo-
denal sondage fluid before cholecystokinin, and figure
3d, the profile of a piece of white string, are practically
identical; similarly figures 3e and 3f correspond very
well, being the profiles of duodenal, sondage fluid after
cholecystokinin and a yellow piece of string respec-
tively. However, it should be noted, by comparison of
the peak heights of the internal standards (peaks num-
bered 3) in figure 3b and figure 3f, which are approxi-
mately the same, and those of the endogenous porphy-
rins (peaks numbered 1,2 and 4), that the concentrations
of the coproporphyrins and protoporphyrin in the string
sample depicted in figure 3f are much higher than in
the string sample depicted in figure 3b. Apparently the
duodenal fluid in the latter sample (fig. 3b) is consider-
ably more dilute than in the former sample (fig. 3f). This
"dilution and concentration" problem has already been
discussed in the Introduction. On the other hand, the
relative concentrations of the porphyrins are essentially
the same, suggesting that ratios of biliary porphyrins
may be used to evaluate whether or not abnormalities in
porphyrin excretion take place. We investigated this is-
sue by calculating ratios of porphyrins in normal native
(hepatic) bile, gall bladder bile and duodenal sondage
fluid, using data published in the literature (12, 13) and
data from the present study. The calculated ratios proto-
poφhyrin/coproporphyrin I, protoporphyrin/copropor-
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Fig. 3 Chromatograms of porphyrins in duodenal fluid (a) ob-
tained without gall bladder stimulation, and in duodenal bile (b)
after artificial gall bladder contraction. The subject was a healthy
volunteer, and the results were obtained with the Enterotest®. Also
shown are chromatograms of porphyrins in duodenal fluid (c and
d) and duodenal bile (e and f) of the same volunteer, obtained by
simultaneously performed duodenal sondage technique (c and e)
and the Enterotest (d and f). For identification of the peaks see
figure-1.
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phyrin III and coproporphyrin I/(coproporphyrin I + III)
are shown in table 2. They demonstrate that, with the
exception of the pΓOtopOφhyrin/coproporphyrin III ra-
tio, these ratios only fluctuate within relatively small
margins in non-porphyric subjects. Subsequent experi-
ments in patients with porphyria variegate, as described
below, made clear that abnormalities or changes in bili-
ary porphyrin profiles can be conveniently represented
by reporting ratios of porphyrin concentrations and com-
paring them with those in normal bile.
Enterotest® results in subjects with variegate
porphyria
The Enterotest® was applied to eight patients known to
have variegate porphyria. In addition a patient was in-
vestigated, who was suspected of suffering from por-
phyria variegata in remission, on the basis of occasional
neurological problems, light sensitivity and abdominal
pain in combination with persistently raised urinary
excretion of coproporphyrins and 5~aminolaevulinic
acid (coproporphyrin I: 6.8 μτηοΐ/τηοΐ creatinine, copro-
porphyrin III: 137 μηηοΐ/mol creatinine and δ-aminolae-
vuliiiic acid: 22 mmol/mol creatinine, normal: lower
than 2.9, 19.0 and 2.2, respectively). However, porpho-
bilinogen and faecal porphyrins were normal. All these
patients swallowed an Enterotest® string at night and
were given a cholecystokinin injection the following day
in a fasting state; 15 minutes later the string was reco-
vered and porphyrin profiles in yellow pieces of string
were determined. The obtained profiles of three of the
known variegate porphyria patients and the patient sus-
pected of variegate porphyria are depicted in figure 4.
Comparison with profiles of normal bile (see fig. 1, 3b,
3e and 3f) revealed typical differences, characteristic for
the presence of variegate porphyria, in particular for the
known variegate porphyria patients. The found concen-
trations of coproporphyrins and protoporphyrin in duo-
denal bile are shown in table 3 and the calculated ratios
in table 2.
Most striking is the considerably raised protoporphyrin
excretion in relation to those of coproporphyrins, re-
flected in abnormally high protoporphyrin/coproporphy-
rin I and protoporphyrin/coproporphyrin III ratios (see
Tab. 2 Mean values, standard deviations and ranges of three por-
phyrin ratios in (duodenal) bile, derived from results obtained by
using the Enterotest® method, in normal subjects and porphyric
patients. Ratios in normal subjects were also compared with ratios
reported previously (12, 13). Enterotest results are designated with
the term "this paper", those from the literature with "others".
* Bile sampled during 21 consecutive days;
** Bile sampled during 17 consecutive days.
Porphyrin ratios
Normal subjects
Normal
This paper
n = 43)
Normal
Others1)
n = 83)
Normal
Others2)
n = 313)
Porphyric subjects
Variegate porphyria
symptomatic in remission
This paper This paper
n = 83) n = I3)
Erythropoietic protoporphyria
Subject A*
This paper
n = 214)
Subject B**
This paper
n = 174)
Protoporphyrin/Coproporphyrin I
Mean
S.D.
Minimum
Maximum
0.14
0.04
0.08
0.20
0.13
0.03
0.10
0.18
0.06
0.03
0.0
0.11
2.14 0.60
0.70
0.9
7.65)
17.3
12.5
1.7
52
5.7
2.7
3.2
15
Protoporphyrin/Coproporphyrin HI
Mean
S.D.
Minimum
Maximum
0.53
0.15
0.39
0.75
0.97
0.46
0.51
1.37
0.20
0.11
0.09
0.32
1.28 1.32
0.64
0.63
2.60
716
560
30
1784
36
32
6
110
Coproporphyrin 1/Coproporphyrin 1 + III
Mean
S.D.
Minimum
Maximum
0.76
0.03
0.73
0.81
0.87
0.03
0.80
0.91
0.76
0.10
0.47
0.86
0.33 0.68
0.1 1
0.22
0.55
0.84
0.08
0.60
0.91
0.81
0.13
0.54
0.91
') Data derived from I.e. (12).
2) Data derived from I.e. (13).
3) Number of different patients, from whom a single sample was
determined.
4) Number of different samples determined from one single pa-
tient.
5) Outlier, omitted in the calculations of mean and S. D.
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Fig. 4 Chromatograms of porphyria in duodenal bile of four sub- Peak number 9: heptacarboxylate porphyrin; 10: hexacarboxylate
jects with variegate porphyria, obtained by means of the En- porphyrin.
terotest® and artificial gallbladder contraction. For further identification of the numbered peaks see figure 1. Peaks
a) subject with variegate porphyria in remission; b)-d) subjects which are not numbered are unknown (porphyrin) compounds,
with symptomatic variegate porphyria.
tab. 2). Coproporphyrin I/(coproporphyrin I + III) ratios
are lower, due to relatively increased coproporphyrin III
levels, while the predominant excretion of coproporphy-
rin I, occurring in normal bile, is less pronounced. In
some patients, coproporphyrin III was even higher than
coproporphyrin I (figure 4c and 4d). In the patient with
variegate porphyria in remission (fig. 4a) the porphyrin
pattern differed less from normal, but the calculated pro-
topoφhyrin/copropoφhyrin I ratio (see tab. 2) was
markedly above the upper normal limit. In combination
with other observed data we concluded that this patient
very likely represented another case of variegate por-
Tab. 3 Mean values, standard deviations and ranges of porphyrin
concentrations (nmol/1), in duodenal bile of 8 subjects with varie-
gate porphyria, and porphyrin concentrations in bile of one subject
with variegate porphyria in remission, all obtained with the En-
terotest®.
Symptomatic variegate porphyria (n = 8)
Mean
S.D.
Minimum
Maximum
Copro-
porphyrin 1
2790
2184
346
6661
Copro- Proto-
porphyrin III porphyrin
5235
3691
1082
10156
10744
10830
1408
27945
Variegate porphyria in remission (n = 1)
349 151 179
phyria. The latter case clearly demonstrates that asymp-
tomatic forms of variegate porphyria may be discovered
by analysis of biliary porphyrins, as previously reported
(5) for duodenal sondage aspirates. The Enterotest® has
the advantage that it offers a more convenient means of
collecting bile for this purpose. An other possible way
to detect asymptomatic carriers of variegate porphyria is
to demonstrate the presence of a putative dicarboxylic
porphyrin peptide complex, only present in subjects with
variegate porphyria, by investigation of fluorescence
emission spectra in plasma (26—29). In our opinion,
however, this method harbours a number of shortcom-
ings, such as lack of sensitivity (5, 29) and the need
of sensitive equipment. In addition, haemolysed plasma
cannot be used, due to interference by Zn-protoporphy-
rin. Another drawback is that no correlations exist be-
tween the severity of the disease and the levels of the
porphyrin-peptide complexes in blood (28).
Longitudinal investigations of biliary
porphyrins in patients with erythropoietic
protoporphyria
Finally a feasibility study was performed as to the poten-
tial use of the Enterotest® for measuring biliary proto-
porphyrin excretion in subjects with erythropoietic pro-
toporphyria. However, we did not have to subject pa-
tients to the Enterotest® procedure, as we had to our
disposal a number of bile samples of two erythropoietic
Eur J Clin Chem Cliri Biochem 1995; 33 (No 7)
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protoporphyria patients (A and B, tab. 2) who had un-
dergone an orthotopic liver transplantation; during some
weeks after this operation bile could be collected from
the T-drain applied in these patients. With regard to the
porphyrin pattern, this material has a composition com-
parable to duodenal bile, as already demonstrated above.
Therefore, it may be assumed that these results are re-
presentative of those obtained with the Enterotest®.
During the first three weeks after orthotopic liver trans-
plantation, the biliary porphyrin patterns of two female
erythropoietic protoporphyria patients were determined;
the results are depicted in figure 5 and relevant ratios in
table 2. The results in this table show that in erythropoi-
etic protoporphyria patients the protoporphyrin/copro-
porphyrin ratios both for coproporphyrin 1 and III are
several times (sometimes more than a thousandfold)
above normal. Figure 5 shows that the concentrations
of protoporphyrin decrease in the first few days after
orthotopic liver transplantation, and that coproporphy-
rins also decrease in patient B, but 10—15 days after
20
Or 0
02000
MOOO
200
100
"· Ο 5 10 15 20 Ο 5 10 15 20
Time after orthotopic liver transplantation [d]
Fig. 5 Time course profiles of porphyrins in bile of two subjects
with erythropoietic protoporphyria, who had undergone an or-
thotopic liver transplantation. Profiles on the left side are from
subject A (see tab. 2), profiles on the right side from subject B.
a) coproporphyrin 1 (solid line) and coproporphyrin III (dashed
line) concentrations;
b) protoporphyrin concentration;
c) ratio protoporphyrin/coproporphyrin I;
d) ratio protoporphyrin/coproporphyrin III.
As far as possible, the same ordinate scales were used for both sub-
jects.
orthotopic liver transplantation the protoporphyrin con-
centrations rise again. The coproporphyrin III concentra-
tions show fewer fluctuations than those of copropor-
phyrin I and protoporphyrin, from which we conclude
that the protopoφhyrin/coproporphyrin III ratio is per-
haps the best quantity for monitoring the biliary proto-
porphyrin excretion. The increased protoporphyrin/
coproporphyrin III ratios reflect the severity of the enzy-
matic block and demonstrate the capacity of the liver to
secrete protoporphyrin adequately. The mean value for
this quantity in an individual patient shows whether or
not biliary protoporphyrin excretion is sufficient. It may
be speculated that a severe drop in this ratio with no
alteration in erythrocyte protoporphyrin concentration
indicates an impaired capability of the liver to excrete
protoporphyrin. Figure 5 clearly demonstrates that sub-
ject A synthesized and excreted considerably more pro-
toporphyrin than subject B. However, more studies are
needed to determine the precise diagnostic value of bili-
ary porphyrin ratios in erythropoietic protoporphyria pa-
tients subjected to the Enterotest®.
At least, this experiment demonstrates the potential use
of porphyrin ratios in bile, which can be obtained by
means of the Enterotest®.
Conclusion
In summary, we have shown that the Enterotest® pro-
cedure constitutes a simple, non-invasive test for meas-
uring the biliary porphyrin composition, enabling the de-
tection of latent variegate porphyria and presumably also
hereditary coproporphyria. It is also potentially useful
for measuring liver protoporphyrin excretion in erythro-
poietic protoporphyria patients. By measuring the por-
phyrin composition in bile instead of faeces, the contri-
bution of bacteria to the porphyrin pattern can be elimi-
nated. Another potential useful application (not investi-
gated here) is the detection of the Dubin-Johnson
syndrome, where the coproporphyrin I/III ratio is known
to be abnormal in bile, as well as in urine (30). Our
experiments further demonstrate that it is highly un-
likely that an enterohepatic circulation of dicarboxylic
porphyrins exists, since we detected secondary dicarb-
oxylic porphyrins in duodenal fluid, and it has been re-
cently reported that these are always completely absent
in serum and bile (13).
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